Managing the Refractory Idiopathic Overactive Bladder with OnabotulinumtoxinA: Phase 2 Trial

被引：0
|
作者：
Boone T.B. [1 ]
机构：
[1] Department of Urology, The Methodist Hospital, Methodist Neurological Institute, Houston, TX, 77030, 6560 Fannin
来源：
Current Bladder Dysfunction Reports | 2011年 / 6卷 / 2期
关键词：
Botulinum Toxin; Detrusor Overactivity; Anticholinergic Medication; onabotulinumtoxinA; Urinary Urgency Incontinence;
D O I：
10.1007/s11884-011-0082-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：65 / 66
页数：1
相关论文
共 50 条
  • [41] THE USE OF ONABOTULINUMTOXINA FOR TREATMENT OF OVERACTIVE BLADDER IN OLDER PATIENTS
    Sammarco, Anne
    Ferry, Elizabeth
    Patel, Dhruti
    Benchek, Penny
    Kikano, Elias
    Hijaz, Adonis
    Mahajan, Sangeeta
    JOURNAL OF UROLOGY, 2015, 193 (04): : E573 - E573
  • [42] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [43] ONABOTULINUMTOXINA DETRUSOR INJECTION IMPROVES FEMALE SEXUAL FUNCTION IN WOMEN WITH IDIOPATHIC WET OVERACTIVE BLADDER SYNDROME
    Balzarro, Matteo
    Rubilotta, Emanuele
    Braga, Andrea
    Bassi, Silvia
    Processali, Tania
    Tamanini, Irene
    Di Dedda, Maria Carmela
    Porcaro, Antonio Benito
    Artibani, Walter
    Serati, Maurizio
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1052 - E1052
  • [44] ONABOTULINUMTOXINA IMPROVES SYMPTOMS OF OVERACTIVE BLADDER, INCLUDING NOCTURIA
    Nitti, Victor
    Dmochowski, Roger
    Sand, Peter
    Thompson, Catherine
    Yan, Xiaohong
    Herschorn, Sender
    NEUROUROLOGY AND URODYNAMICS, 2013, 32 (02) : 109 - 110
  • [45] Managing Overactive Bladder Syndrome
    Breese, Charles R.
    Breese, Donna M.
    US PHARMACIST, 2024, 49 (09)
  • [46] Cost Effectiveness of Sacral Neuromodulation and Botulinum Toxin A in Managing Refractory Overactive Bladder
    Hadidi, S.
    Atiiga, P. A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 258 - 258
  • [47] Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder EDITORIAL COMMENT
    Weidner, Alison
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2019, 74 (04) : 209 - 210
  • [48] OnabotulinumtoxinA FOR NON NEUROGENIC OVERACTIVE BLADDER : OUR EXPERIENCE
    Tamburro, Fabiola Raffaella
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S33 - S34
  • [49] Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
    Stading, Rachel
    Hernandez, Natalia
    Pacheco, Julian
    Miceli, Lia
    Antosh, Danielle D.
    Stewart, Julie N.
    Gonzalez, Ricardo
    Santiago-Lastra, Yahir
    Khavari, Rose
    CONTINENCE, 2024, 12
  • [50] One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications
    Farrelly, Elisabeth
    Hamid, Rizwan
    Lorenzo-Gomez, Maria-Fernanda
    Schulte-Baukloh, Heinrich
    Yu, Jun
    Patel, Anand
    Nelson, Mariana
    NEUROUROLOGY AND URODYNAMICS, 2023, 42 (06) : 1203 - 1213
12345